Associated Papers
Detailed Clinical, Ophthalmic, and Genetic Characterization of MYO7A-Associated Usher Syndrome.
Romo-Aguas JC et al.
Investigative Ophthalmology & Visual Science, 2025
40257781 (PubMed )
Supplement: iovs-66-4-60_s002.xlsx › Genetic_results
Systematic genetic assessment of hearing loss using whole-genome sequencing identifies pathogenic variants.
Kim JA et al.
Experimental & Molecular Medicine, 2025
40164689 (PubMed )
Supplement: 12276_2025_1428_MOESM1_ESM.pdf
Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
Testa F et al.
Investigative Ophthalmology & Visual Science, 2024
38884554 (PubMed )
Supplement: iovs-65-6-25_s003.xlsx › DOMAIN_annotation
GESPA: classifying nsSNPs to predict disease association.
Khurana JK et al.
Bmc Bioinformatics, 2015
26206375 (PubMed )
Supplement: 12859_2015_673_MOESM2_ESM.xls › Sheet1
Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%.
Roux AF et al.
Journal of Medical Genetics, 2006
Novel mutations in MYO7A and USH2A in Usher syndrome.
Maubaret C et al.
Ophthalmic Genetics, 2005
Select a paper to view details